Agios Pharmaceuticals Inc (NASDAQ:AGIO)

107.28
Delayed Data
As of Feb 27
 -0.48 / -0.45%
Today’s Change
28.81
Today|||52-Week Range
138.85
-4.25%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Celgene Corp
Buy12/16/2014228,645$110.75$25.3M-0.18%
Biller Scott
Chief Scientific Officer
Sale9/19/201437,996$50.45$1.9M+119.34%
Schenkein David Paul
Chief Executive Officer
Sale9/26/201430,000$62.68$1.9M+68.26%
Schenkein David Paul
Chief Executive Officer
Sale9/26/201430,000$62.68$1.9M+68.26%
Goddard Glenn /archemix/
Senior Vice President-Finance
Sale2/09/201515,000$105.81$1.6M+1.25%
Higgons John Duncan
Chief Operating Officer
Sale1/02/201512,000$110.08$1.3M-2.26%
Higgons John Duncan
Chief Operating Officer
Sale1/02/201512,000$110.08$1.3M-2.26%
Higgons John Duncan
Chief Operating Officer
Sale12/01/201412,000$97.03$1.2M+11.44%
Higgons John Duncan
Chief Operating Officer
Sale11/03/201413,000$81.71$1.1M+29.14%
Goddard Glenn /archemix/
Senior Vice President-Finance
Sale9/26/201417,500$56.53$989.3K+68.26%
Page of 14

To view my watchlist

Not a member yet?

Sign up now for a free account